Skip to Main Content

Paper Details

FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia.
Clin Cancer Res
90
2015
Author NameAffiliation
Nicole VerdunCenter for Drug Evaluation and Research
  • 1 - 1

Datasets

Release 1.2